Log in

NASDAQ:NVIVInvivo Therapeutics SEC Filings & 10K Form

$1.57
+0.03 (+1.95 %)
(As of 04/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$1.54
Now: $1.57
$1.73
50-Day Range
$1.22
MA: $3.70
$7.54
52-Week Range
$1.09
Now: $1.57
$50.70
Volume145,238 shs
Average Volume314,640 shs
Market Capitalization$926,300.00
P/E RatioN/A
Dividend YieldN/A
Beta1.92

SEC Filings

Invivo Therapeutics (NASDAQ:NVIV) SEC Filings

DateFilerForm TypeView
03/12/2020
6:01 PM
Invivo Therapeutics (Issuer)
Toselli Richard M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2020
6:01 PM
CHRISTOPHER RICHARD (Reporting)
Invivo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2020
6:01 PM
Invivo Therapeutics (Issuer)
MERRIFIELD C ANN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2020
4:09 PM
Invivo Therapeutics (Filer)
Form 424B4
03/08/2020
11:21 PM
Invivo Therapeutics (Filer)
Form EFFECT
03/02/2020
3:05 PM
Invivo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/24/2020
3:31 PM
Invivo Therapeutics (Filer)
Form 8-K/A
02/20/2020
3:54 PM
Invivo Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/24/2020
3:31 PM
Invivo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2020
3:30 PM
Invivo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2019
4:23 PM
Invivo Therapeutics (Issuer)
Toselli Richard M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2019
3:33 PM
Invivo Therapeutics (Filer)
Form 8-K/A
11/21/2019
8:42 PM
Invivo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2019
8:41 PM
Invivo Therapeutics (Filer)
Form 424B5
11/20/2019
8:34 PM
Invivo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2019
8:33 PM
Invivo Therapeutics (Filer)
Form 424B3
11/20/2019
8:33 PM
Invivo Therapeutics (Filer)
Form 424B3
11/18/2019
7:02 AM
Invivo Therapeutics (Filer)
Form 424B5
11/14/2019
11:15 PM
Invivo Therapeutics (Filer)
Form EFFECT
11/12/2019
7:31 AM
Invivo Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/12/2019
6:45 AM
Invivo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2019
4:19 PM
Invivo Therapeutics (Filer)
Form PRE 14A
11/07/2019
3:31 PM
Invivo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/28/2019
3:34 PM
Invivo Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/27/2019
6:41 PM
Invivo Therapeutics (Issuer)
Toselli Richard M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2019
6:39 PM
Invivo Therapeutics (Issuer)
Toselli Richard M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2019
6:38 PM
CHRISTOPHER RICHARD (Reporting)
Invivo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2019
3:30 PM
Invivo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2019
7:01 AM
Invivo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/19/2019
3:30 PM
Invivo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2019
7:11 AM
Invivo Therapeutics (Filer)
Form DEFA14A
07/12/2019
7:05 AM
Invivo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2019
7:00 AM
Invivo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/30/2019
11:15 PM
Invivo Therapeutics (Filer)
Form EFFECT
06/21/2019
7:01 AM
Invivo Therapeutics (Filer)
Form POS AM
06/14/2019
7:05 AM
Invivo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2019
6:50 AM
Invivo Therapeutics (Filer)
Form DEFA14A
06/05/2019
7:09 AM
Invivo Therapeutics (Filer)
Form DEFA14A
06/05/2019
7:06 AM
Invivo Therapeutics (Filer)
Form DEFA14A
05/29/2019
11:15 PM
Invivo Therapeutics (Filer)
Form EFFECT
05/22/2019
4:55 PM
Invivo Therapeutics (Issuer)
Toselli Richard M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
3:33 PM
Invivo Therapeutics (Filer)
Form POS AM
05/10/2019
7:01 AM
Invivo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2019
4:20 PM
Invivo Therapeutics (Filer)
Form DEF 14A
04/24/2019
8:43 PM
Invivo Therapeutics (Issuer)
Toselli Richard M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2019
4:13 PM
Invivo Therapeutics (Filer)
Form PRE 14A
04/01/2019
7:08 AM
Invivo Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/01/2019
7:02 AM
Invivo Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/20/2019
5:29 PM
Invivo Therapeutics (Issuer)
Toselli Richard M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2019
3:10 PM
Invivo Therapeutics (Issuer)
Toselli Richard M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2019
7:28 PM
Invivo Therapeutics (Issuer)
Toselli Richard M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2019
3:41 PM
CHRISTOPHER RICHARD (Reporting)
Invivo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2019
3:39 PM
CHRISTOPHER RICHARD (Reporting)
Invivo Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/14/2019
4:29 PM
Invivo Therapeutics (Filer)
Form 424B3
01/14/2019
4:28 PM
Invivo Therapeutics (Filer)
Form 424B3
01/14/2019
4:25 PM
Invivo Therapeutics (Filer)
Form 424B3
01/14/2019
4:21 PM
Invivo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2019
3:46 PM
Invivo Therapeutics (Filer)
Form 424B3
01/04/2019
3:46 PM
Invivo Therapeutics (Filer)
Form 424B3
01/04/2019
3:40 PM
Invivo Therapeutics (Filer)
Form 424B3
01/04/2019
3:38 PM
Invivo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2018
2:03 PM
Invivo Therapeutics (Issuer)
Toselli Richard M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2018
8:05 AM
Invivo Therapeutics (Filer)
Form 424B3
12/14/2018
8:01 AM
Invivo Therapeutics (Filer)
Form 424B3
12/14/2018
7:53 AM
Invivo Therapeutics (Filer)
Form 424B3
12/14/2018
7:48 AM
Invivo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/16/2018
4:03 PM
Invivo Therapeutics (Filer)
Form 424B3
11/16/2018
3:57 PM
Invivo Therapeutics (Filer)
Form 424B3
11/16/2018
3:51 PM
Invivo Therapeutics (Filer)
Form 424B3
11/16/2018
3:45 PM
Invivo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2018
7:15 AM
Invivo Therapeutics (Filer)
Form 424B3
11/13/2018
7:14 AM
Invivo Therapeutics (Filer)
Form 424B3
11/13/2018
7:05 AM
Invivo Therapeutics (Filer)
Form 424B3
11/13/2018
7:00 AM
Invivo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2018
3:12 PM
Invivo Therapeutics (Filer)
Form 424B3
11/08/2018
3:10 PM
Invivo Therapeutics (Filer)
Form 424B3
11/08/2018
3:07 PM
Invivo Therapeutics (Filer)
Form 424B3
11/08/2018
3:02 PM
Invivo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/05/2018
4:11 PM
Invivo Therapeutics (Filer)
Form 424B3
10/05/2018
4:03 PM
Invivo Therapeutics (Filer)
Form 424B3
10/05/2018
4:02 PM
Invivo Therapeutics (Filer)
Form 424B3
10/05/2018
3:28 PM
Invivo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/28/2018
4:23 PM
Invivo Therapeutics (Filer)
Form 424B3
09/28/2018
4:22 PM
Invivo Therapeutics (Filer)
Form 424B3
09/28/2018
4:21 PM
Invivo Therapeutics (Filer)
Form 424B3
09/28/2018
7:10 AM
Invivo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2018
3:06 PM
Invivo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2018
3:47 PM
Invivo Therapeutics (Filer)
Form 424B3
08/07/2018
3:04 PM
Invivo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/29/2018
7:42 AM
CVI Investments, Inc. (Filed by)
Invivo Therapeutics (Subject)
Form SC 13G
06/26/2018
3:32 PM
Invivo Therapeutics (Filer)
Form 424B4
06/25/2018
3:06 PM
Anson Funds Management LP (Filed by)
Invivo Therapeutics (Subject)
Form SC 13G
06/25/2018
12:50 PM
Invivo Therapeutics (Subject)
SABBY MANAGEMENT, LLC (Filed by)
Form SC 13G
06/22/2018
1:02 PM
Invivo Therapeutics (Filer)
Form 424B4
06/21/2018
8:18 AM
Invivo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2018
11:15 PM
Invivo Therapeutics (Filer)
Form EFFECT
06/20/2018
8:55 PM
Invivo Therapeutics (Filer)
Form S-1MEF
06/19/2018
7:37 AM
Invivo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2018
3:45 PM
Invivo Therapeutics (Subject)
Form FWP
06/14/2018
3:43 PM
Invivo Therapeutics (Filer)
Form S-1/A
This page was last updated on 4/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel